Playback speed
10 seconds
ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fixed-Dose Combination of Pertuzumab & Trastuzumab for Subcutaneous Injection for At-Home Administration in HER2+ BC During the COVID-19 Pandemic
By
ASCO 2022 Conference Coverage
FEATURING
Chau Dang
By
ASCO 2022 Conference Coverage
FEATURING
Chau Dang
198 views
June 21, 2022
Login to view comments.
Click here to Login